Literature DB >> 16172204

The choice of antipsychotic drugs for schizophrenia.

Robert Freedman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16172204     DOI: 10.1056/NEJMe058200

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  Prices, profits, and innovation: examining criticisms of new psychotropic drugs' value.

Authors:  Haiden A Huskamp
Journal:  Health Aff (Millwood)       Date:  2006 May-Jun       Impact factor: 6.301

2.  Who are the new users of antipsychotic medications?

Authors:  Marisa Elena Domino; Marvin S Swartz
Journal:  Psychiatr Serv       Date:  2008-05       Impact factor: 3.084

3.  Intentional rechallenge: does the benefit outweigh the risk?

Authors:  Vid Stanulović; Mauro Venegoni; Brian Edwards
Journal:  Drug Saf       Date:  2013-03       Impact factor: 5.606

4.  Fine-tuning of awake prefrontal cortex neurons by clozapine: comparison with haloperidol and N-desmethylclozapine.

Authors:  Houman Homayoun; Bita Moghaddam
Journal:  Biol Psychiatry       Date:  2006-10-13       Impact factor: 13.382

Review 5.  Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms.

Authors:  G Mudo; N Belluardo; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2006-08-17       Impact factor: 3.575

6.  Attenuated Weight Gain with the Novel Analog of Olanzapine Linked to Sarcosinyl Moiety (PGW5) Compared to Olanzapine.

Authors:  Michal Taler; Israel Vered; Rea Globus; Liat Shbiro; Abraham Weizman; Aron Weller; Irit Gil-Ad
Journal:  J Mol Neurosci       Date:  2015-11-14       Impact factor: 3.444

7.  Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization.

Authors:  Hua Jin; Pei-an Betty Shih; Shahrokh Golshan; Sunder Mudaliar; Robert Henry; Danielle K Glorioso; Stephan Arndt; Helena C Kraemer; Dilip V Jeste
Journal:  J Clin Psychiatry       Date:  2012-11-27       Impact factor: 4.384

Review 8.  Asenapine.

Authors:  Juliane Weber; Paul L McCormack
Journal:  CNS Drugs       Date:  2009-09       Impact factor: 5.749

Review 9.  Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.

Authors:  Rodrigo D Paz; Sonia Tardito; Marco Atzori; Kuei Y Tseng
Journal:  Eur Neuropsychopharmacol       Date:  2008-07-23       Impact factor: 4.600

10.  Passive and active schizophrenia: toward a new descriptive micropsychopathology.

Authors:  Massimo Moscarelli
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.